Drug details

Raxibacumab (human igg1λ monoclonal antibody intravenous infusion)

type of Antidotes, Other

Raxibacumab Injection is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.

The following drugs are related to Raxibacumab, either as a replacement or used together:

• Acticlate (doxycycline hyclate tablets, usp)
• Adoxa (doxycyline capsules)
• Atridox (doxycycline hyclate)
• Cipro (ciprofloxacin)
• Cipro I.V. (ciprofloxacin iv)
• Cipro XR (ciprofloxacin extended-release)
• Ciprodex (ciprofloxacin and dexamethasone)
• Doryx (doxycycline hyclate)
• Oracea (doxycycline)
• Vibramycin (doxycycline calcium oral)
• Vibramycin Intravenous (doxycycline hyclate)
• Levaquin (levofloxacin)
• Noroxin (norfloxacin)